4//SEC Filing
Burkavage Brian 4
Accession 0001567619-22-012194
CIK 0001865494other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 6:25 PM ET
Size
5.5 KB
Accession
0001567619-22-012194
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Burkavage Brian
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-31+20,000→ 20,000 totalExercise: $4.83Exp: 2032-05-31→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on 5/31/2023, and 1/48th of these options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 50% acceleration upon a change of control and subject to 100% acceleration upon termination of service by the Issuer without cause within 24 months of a change of control.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001865633
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 6:25 PM ET
- Size
- 5.5 KB